The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation

Am J Cardiol. 1990 Aug 1;66(3):366-7. doi: 10.1016/0002-9149(90)90851-q.
No abstract available

MeSH terms

  • Anilides / adverse effects
  • Animals
  • Anti-Arrhythmia Agents / adverse effects*
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation / drug therapy*
  • Encainide
  • Flecainide / adverse effects
  • Hemodynamics / drug effects
  • Humans
  • Propafenone / adverse effects

Substances

  • Anilides
  • Anti-Arrhythmia Agents
  • Propafenone
  • Flecainide
  • Encainide